hypercalcaemia
Metabolic · 2020–2024
2decisions
2medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| milk powder synthetic, low calcium oral powder Dietary management of hypercalcaemia in patients under 4 years of age. | Jul 2024 | Recommended | none received |
| milk powder synthetic low calcium Dietary management of hypercalcaemia in patients under the age of four years (inclusive). | Jul 2020 | Recommended with restriction | none received |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.